Suchergebnisse - (Subject:"Adalimumab")

PubPharm (8)

1

Adalimumab in Japanese patients with active ulcers of pyoderma gangrenosum : Final analysis of a 52-week phase 3 open-label study

enthalten in: The Journal of dermatology | 2022

von Yamasaki, K. | Yamanaka, K. | Zhao, Y. | +4

2

Long-term analysis of adalimumab in Japanese patients with moderate to severe hidradenitis suppurativa : Open-label phase 3 results

enthalten in: The Journal of dermatology | 2021

von Morita, A. | Takahashi, H. | Ozawa, K. | +11

3

Adalimumab in Japanese patients with active ulcers of pyoderma gangrenosum : Twenty-six-week phase 3 open-label study

enthalten in: The Journal of dermatology | 2020

von Yamasaki, K. | Yamanaka, K. | Zhao, Y. | +4

4

Consistent responses with guselkumab treatment in Asian and non-Asian patients with psoriasis : An analysis from VOYAGE 1 and VOYAGE 2

enthalten in: The Journal of dermatology | 2019

von Reich, K. | Song, M. | Li, S. | +6

5

Twenty-four-week interim analysis from a phase 3 open-label trial of adalimumab in Japanese patients with moderate to severe hidradenitis suppurativa

enthalten in: The Journal of dermatology | 2019

von Morita, A. | Takahashi, H. | Ozawa, K. | +11

6

Adalimumab treatment in Japanese patients with generalized pustular psoriasis : Results of an open-label phase 3 study

enthalten in: The Journal of dermatology | 2018

von Morita, A. | Yamazaki, F. | Matsuyama, T. | +9

7

Adalimumab treatment optimization for psoriasis : Results of a long-term phase 2/3 Japanese study

enthalten in: The Journal of dermatology | 2015

von Asahina, A. | Ohtsuki, M. | Etoh, T. | +5

8

Adalimumab in Japanese patients with moderate to severe chronic plaque psoriasis : efficacy and safety results from a Phase II/III randomized controlled study

enthalten in: The Journal of dermatology | 2010

von Asahina, A. | Nakagawa, H. | Etoh, T. | +61

1
[1]